Mar 17, 2026

Email 1:

Subject: Organ transplants, disability accommodations, and ‘The Fugitive’ insights

• Organ transplants are being transformed by new technologies like warm and cold perfusion and updated protocols for retrieval, resulting in shorter wait times and fewer deaths on waiting lists. However, experts are concerned about cost and equitable access.
• Disabled CDC workers face ongoing challenges obtaining needed accommodations after a temporary revocation of remote work permissions. A letter from union president Yolanda Jacobs details harms caused by lack of accommodations, including medical events and AWOL classifications. HHS disputes these claims.
• New cardiovascular guidelines recommend considering statins as early as age 30, reflecting updated approaches to prevention and treatment.
• STAT created a video imagining how the events of the movie “The Fugitive” would be covered if real, including how reporters would investigate a pharmaceutical fraud scandal.
• Study suggests expanding surveillance of severe maternal morbidity to include periods before and after delivery, which could capture more cases.
• Personal essay highlights the loss of hope experienced by an ALS gene carrier as changes in policy reduced research support.

Email 2:

Subject: Autism therapy crackdown and AI’s health care impact

• States and Medicaid insurers are scrutinizing applied behavioral analysis (ABA) autism therapy due to skyrocketing costs, dubious billing practices, and inconsistent care quality. Private equity owns many centers, intensifying concerns.
• Federal audits uncovered tens of millions in improper Medicaid payments; outright fraud cases have also emerged.
• AI transcription and billing tools promise efficiency but are inflating diagnoses and costs by hallucinating procedures, adding hundreds of millions in spending and complicating clinical documentation.
• Microsoft launches an AI health assistant called Copilot Health, synthesizing medical records and device data to provide personalized advice without formal diagnosis; currently free but with privacy considerations as HIPAA does not cover AI chatbots.
• The White House enhances oversight of HHS communications; medical device manufacturer Stryker responds to a cyberattack; U.S. poultry vaccine policies lag behind other nations.

Email 3:

Subject: Science news roundup — RAM shortage, China’s tech ambitions, and AI in academia

• Global RAM chip shortages driven by AI demand are raising prices and straining research labs; supply may take 18+ months to catch up.
• China’s new five-year plan aims for leadership in AI, quantum tech, and self-sufficiency, including domestic semiconductor production, marking a confident shift from a catch-up stance.
• Educators respond to controversial AI tools that automate homework and lectures, raising concerns about cheating and diminished human interaction.
• Graduate students view AI as both a helpful tool and a potential threat to research and writing skills.
• Canada invests nearly $1 billion to attract top international researchers but faces critiques about neglecting emerging domestic talent and equity considerations.
• Feature images and quotes explore fossil discoveries and ethical considerations of species “de-extinction.”

Email 4:

Subject: Last call to join STAT Breakthrough Summit East in NYC

• Registration for the STAT Breakthrough Summit East happening this week in NYC is closing soon.
• Limited in-person General Admission and Agency & Sales passes remain; General Admission is 90% sold out.
• Attendees include high-level biotech, pharma, and healthcare leaders (CEOs, CMOs, CSOs, executives).
• Featured speakers include Dr. Rob Califf (former FDA Commissioner), Sharon Mates (CEO Intra-Cellular Therapies), Chris Klomp (CMS Deputy Administrator), and others.
• Option to watch virtually is available with a 40% discount.

Email 5:

Subject: Federal judge halts major RFK Jr. vaccine policy changes

• A federal judge in Boston preliminarily blocked key components of Health Secretary Robert F. Kennedy Jr.’s overhaul of U.S. vaccine policy.
• The judge ruled that the Trump administration likely violated laws in reconstituting a vaccine advisory panel and altering the childhood vaccine schedule.
• While not final, this decision is a significant setback for the administration’s vaccine reform efforts.
• Related coverage discusses White House statements on vaccines, reduced FDA public advisory meetings, and a STAT exploration of how “The Fugitive” pharma scandal would be covered if real.
• Readers are encouraged to join STAT+ for full access to in-depth reporting and data tools.

Stay Well!